Biotech · Private company · Bedminster, NJ, US
Intra-Cellular Therapies, Inc.
SEC CIK 0001567514
Track this companyFree. Adds Intra-Cellular Therapies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2513 recruiting or active
Pipeline programs27From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline27
- ITI-007 (Lumateperone)Phase 3 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284Phase 3 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-99245354Phase 3 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- LumateperonePhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- LumateperonePhase 3 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- LumateperonePhase 3 · Bipolar Disorder, ManicClinicalTrials.gov · fetched Nov 12, 2026
- LumateperonePhase 3 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 42 mgPhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone high dosePhase 3 · Irritability Associated With Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone low dosePhase 3 · Irritability Associated With Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284Phase 2 · Psychotic DisordersClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284Phase 2 · Agitation Associated With Alzheimer's DementiaClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284 10 mgPhase 2 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284 20 mgPhase 2 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- LenrispodunPhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284 10 mgPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ITI-1284 20 mgPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ITI-333Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 10.5 mg capsulePhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 10.5 mg ODTPhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 15.5 mg ODTPhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 21 mg capsulePhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 21 mg ODTPhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 28 mgPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone 5 mg ODTPhase 1 · Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone CapsulePhase 1 · Schizophrenia or SchizoaffectiveClinicalTrials.gov · fetched Nov 12, 2026
- Lumateperone LAIPhase 1 · Schizophrenia or SchizoaffectiveClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD TreatmentPHASE3 · RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07856420 · fetched Nov 12, 2026
- A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)PHASE3 · RECRUITING · started Sep 3, 2026ClinicalTrials.gov NCT07807865 · fetched Nov 12, 2026
- Lumateperone for Late-Life DepressionPHASE3 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07623135 · fetched Nov 12, 2026
- Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsPHASE3 · RECRUITING · started Dec 6, 2024ClinicalTrials.gov NCT06706674 · fetched Nov 12, 2026
- Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric PatientsPHASE3 · RECRUITING · started Nov 22, 2024ClinicalTrials.gov NCT06690398 · fetched Nov 12, 2026
- Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderPHASE2 · RECRUITING · started Nov 21, 2024ClinicalTrials.gov NCT06701903 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPHASE2 · RECRUITING · started Oct 22, 2024ClinicalTrials.gov NCT06651567 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective DisorderPHASE1 · COMPLETED · started Aug 23, 2024ClinicalTrials.gov NCT06627413 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseasePHASE2 · RECRUITING · started Aug 15, 2024ClinicalTrials.gov NCT06540833 · fetched Nov 12, 2026
- Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderPHASE2 · RECRUITING · started Aug 5, 2024ClinicalTrials.gov NCT06480383 · fetched Nov 12, 2026
- Study of Lumateperone in the Treatment of Patients With Bipolar ManiaPHASE3 · COMPLETED · started Jul 17, 2024ClinicalTrials.gov NCT06462612 · fetched Nov 12, 2026
- Study of Lumateperone in the Acute Treatment of Patients With Bipolar ManiaPHASE3 · COMPLETED · started Jun 19, 2024ClinicalTrials.gov NCT06462586 · fetched Nov 12, 2026
- Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPHASE3 · RECRUITING · started May 14, 2024ClinicalTrials.gov NCT06372964 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum DisorderPHASE1 · COMPLETED · started May 10, 2024ClinicalTrials.gov NCT06557902 · fetched Nov 12, 2026
- PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy SubjectsPHASE1 · COMPLETED · started Apr 11, 2024ClinicalTrials.gov NCT06299410 · fetched Nov 12, 2026
- Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With SchizophreniaPHASE4 · RECRUITING · started Apr 2, 2024ClinicalTrials.gov NCT06174116 · fetched Nov 12, 2026
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderPHASE3 · RECRUITING · started Jan 25, 2024ClinicalTrials.gov NCT06229210 · fetched Nov 12, 2026
- Caplyta in Borderline Personality DisorderPHASE2 · COMPLETED · started May 10, 2023ClinicalTrials.gov NCT05356013 · fetched Nov 12, 2026
- Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPHASE3 · RECRUITING · started May 2, 2023ClinicalTrials.gov NCT05850689 · fetched Nov 12, 2026
- Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePHASE2 · COMPLETED · started Mar 13, 2023ClinicalTrials.gov NCT05766813 · fetched Nov 12, 2026
- Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy VolunteersPHASE1 · COMPLETED · started Jan 18, 2023ClinicalTrials.gov NCT05732194 · fetched Nov 12, 2026
- An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPHASE3 · COMPLETED · started Oct 8, 2021ClinicalTrials.gov NCT05061719 · fetched Nov 12, 2026
- Lumateperone for the Prevention of Relapse in Patients With SchizophreniaPHASE3 · COMPLETED · started Jul 8, 2021ClinicalTrials.gov NCT04959032 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective DisorderPHASE1 · COMPLETED · started Mar 12, 2021ClinicalTrials.gov NCT04779177 · fetched Nov 12, 2026
- Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar DepressionPHASE3 · COMPLETED · started Dec 15, 2015ClinicalTrials.gov NCT02600494 · fetched Nov 12, 2026
SEC filings10
- 8-K · 8-KSEC EDGAR · filed Apr 2, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 27, 2025 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Mar 20, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 18, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 3, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 21, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 21, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 13, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 10, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 3, 2024 · fetched Nov 12, 2026